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Background/Aims: Recent outbreak of hepatitis A in Korea is clearly related to the epidemiological shift of hepatitis A virus 
(HAV). However, nationwide seroprevalence data have been limited. This study estimated the nationwide, age- and 
area-adjusted anti-HAV prevalence from 2005 to 2009. Methods: Retrospective analysis of the results of total anti-HAV test in 
25,140 cases which were requested by 1,699 medical institutions throughout the nation to Seoul Clinical Laboratory from Jan. 1 
2005 to Dec. 31 2009 was performed. The estimated seroprevalence was adjusted by area and age of the standard population 
based on the 2005 Census data from Korea National Statistical Office. Results: The area-adjusted anti-HAV prevalence in the 
children younger than 10 years were 33.4% in 2005 and 69.9% in 2009. The most susceptible age groups to HAV infection during 
the last 5 years were teenagers and the young adults in their age of twenties. The area-adjusted seroprevalence in 2009 were 
11.9% in the age group of 20-29 years, 23.4% in the age group of 10-19 years, 48.4% in the age group of 30-39 years. The 
population in 40-49 years showed geographically different seroprevalence with the lowest rate in Seoul (80%). Conclusions: The 
most susceptible age group to HAV infection is 10-29 years, while the young children less than 10 years showed about 70% 
seropositivity. The changing seroepidemiology should be monitored continuously for the proper vaccination and patient care. 
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INTRODUCTION
Hepatitis A virus (HAV) causes around 80% of acute 
hepatitis in South Korea and its clinical manifestation is 
mild in children but is severe in many adults.
1 The number of 
cases of hepatitis A reported to Korea Centers for Disease 
Control and Prevention increased sharply from 798, 2,081 
and 2,233 in 2005, 2006 and 2007, respectively to 7,895 and 
15,231 in 2008 and 2009, respectively.
2 These are data from 
surveillance reporting system, while the numbers of claims 
actually made to National Health Insurance Cooperation are 
at least 3-4 times higher than them. However, this increase of 
symptomatic hepatitis in adults does not mean the increase 
of infection rate of HAV around the nation. Before 1990, 
most Koreans were infected with HAV before they were in 
their 20s and over 90% of the public already had protective 
antibodies in their 20s, so the incidence rate of symptomatic 
hepatitis A in adult population was low. With the improvement Donghun Lee, et al. A nationwide seroprevalence of hepatitis A virus from 2005 to 2009  45
Table 1. Demographic characteristics of the subjects
Variable
Year
Total
2005 2006 2007 2008 2009
Number
Age (mean±S.D)
Male:Female ratio
Age group
   0-09
  10-19
  20-29
  30-39
  40-49
  50-59
  60-
1,140
31.0±20.4
1:0.76
231
141
171
225
156
104
112
1,642
34.1±18.4
1:0.82
158
224
314
341
265
180
160
2,050
35.7±17.7
1:0.74
151
245
347
470
393
255
189
6,207
37.6±17.4
1:1.00
401
445
1,127
1,540
1,203
775
716
14,101
38.4±14.9
1:1.08
294
1,049
2,500
4,191
2,991
1,819
1,257
25,140
37.4±16.4
1:0.99
1,235
2,104
4,459
6,767
5,008
3,131
2,434
of the sanitary condition associated with the current economic 
development, the nationwide infection of HAV was reduced 
significantly while young adults and adolescents aged less 
than 40 years became more vulnerable to the infection 
because most of them do not have the protective antibody 
following natural infection. As the clinical manifestation of 
hepatitis A tends to be mild in children but severe in about 
80% cases of adults, the cases of severe symptomatic hepatitis 
A are felt to be raised in recent years. 
The current epidemic of hepatitis A was observed mainly 
in Seoul, Gyeonggi and Incheon and it spreads around the 
nation.
1,3 Although the patients are usually in their 20s and 
30s, the number of symptomatic hepatitis patients aged over 
40s has been increasing these days. Epidemiological studies 
on the prevalence of hepatitis A antibody (anti-HAV) have 
been conducted continuously since the late 1990, but most of 
them investigated limited areas, had a small number of 
subjects or were performed for a short period and there have 
not been sufficient researches examining the nationwide 
antibody positive rates by year and age. Therefore, the authors 
analyzed the results of 45,296 hepatitis A antibody tests 
from Seoul Clinical Laboratories (SCL) requested by 1,699 
medical institutions around the nation for the last five years, 
to determine total anti-HAV positive rates by year, age and 
area. Moreover, it obtained age- and area-adjusted anti-HAV 
positive rates with the population in 2005 Census as a 
standard population.
MATERIALS AND METHODS
Materials
This study examined the results of 45,296 cases for whom anti- 
HAV tests were requested to SCL by 1,699 medical institutions 
around the nation from January 2005 to December 2009. Out of 
them 20,156 patients took IgM anti-HAV test as well as total 
anti-HAV, and they were excluded in this study because they 
were considered to contain hepatitis A patients. So, the final 
subjects of this study were 25,140. The subjects gradually 
increased from 1,140 in 2005 to 14,101 in 2009, but the ratios of 
males and females were similar. Their mean age became higher 
from 31.0±20.4 years in 2005 to 38.4±14.9 years in 2009 (Table 1). 
This study was approved by Institutional Review Board of Seoul 
Medical Science Institute (SMSI).
Antibody test
Total anti-HAV test was conducted with electro-chemi-
luminescence immunoassay (ECLIA) by using Modular 
analytics E170 (Elecsys module, Roche Diagnostics GmbH, 
Manheim, Germany).
Statistical analysis
Anti-HAV positive rates of all age groups were investigated 
by dividing age at a five year interval. The data were primarily 
analyzed by area and year of test. The number of cases of the 
test was significantly higher in 2009 than in 2005 and the 
number of subjects living in the capital area was also higher 
than that in other areas. So, age- and area-adjusted positive 
rates by year were calculated with the population in 2005 
Census as the standard population by classifying age at a 
10-year interval and by arbitrarily dividing area into Seoul, 
Incheon/Gyeonggi/Gangwon, Chungcheong, Honam/Jeju and 
Gyeongsang. Using direct standardized method, all expected 
numbers of anti-HAV positive persons was calculated in the 
five areas and six age groups. For example, the expected 46  The Korean Journal of Hepatology Vol. 17. No. 1, March 2011
Table 2. Area-adjusted anti-HAV seroprevalence rate (%) by year and age
*
Variable 
Year
2005 2006 2007 2008 2009
0-9 33.4 52.7  42.6 50.7 69.9 
10-19 15.3 18.9  20.1 25.5 23.4 
20-29 23.1 29.0  19.4 17.4 11.9 
30-39 69.9 67.6  63.9 58.6 48.4 
40-49 97.9 96.7  94.6 91.4 89.0 
50+ 98.7 98.1  98.0 99.0 98.8 
Area and age-adjusted rate 62.5  65.4  61.8  61.9  60.7 
  (95% confidence interval) (62.47, 62.51) (65.37, 65.42) (61.78, 61.82) (61.87, 61.91) (60.68, 60.72)
* Area was grouped as Seoul, Incheon+Gyeonggi+Gangwon, Chungcheong, Honam+Jeju, and Gyeongsang. 2005 Census population 
was used for standard population.
HAV, hepatitis A virus.
number of anti-HAV positive persons in Seoul was obtained 
by adjusting the antibody positive rate of the subjects to the 
standard population of each age group and the sum of the 
expected numbers was divided by the sum of the standard 
population in Seoul. Statistical analysis was conducted with 
SPSS 15.0 and the positive rates by area and year were 
compared by using Pearson Chi-square test and Fischer's 
Exact test. A P-value of less than 0.05 was considered to be 
statistically significant.
RESULTS
Anti-HAV positive rate by area and year from 
2005 to 2009
Although the total positive rates by year were examined by 
dividing age group at a 5-year interval from 2005 to 2009, it was 
hard to have accurate positive rates by age and area because of 
insufficient numbers of subjects by age and area. Therefore, the 
area was groups into 5 area districts and the age was classified at 
a 10-year interval for a direct standardization, to obtain stand-
ardized anti-HVA positive rate by age and year. The standardized 
rates showed a statistically significant difference compared to the 
previous year or the following year (P<0.001, Table 2). For age, 
the positive rate of young children aged less than 10 years 
increased sharply around the nation from 33.4% in 2005 to 
69.9% in 2009. The age with the lowest positive rates from 2005 
to 2009 was 10-29 years. The positive rate of the persons in their 
10s went up slightly from 15.3% in 2005 to 23.4% in 2009 but 
that of the persons in their 20s was reduced from 23.1% in 2005 
to 11.9% in 2009. The prevalence rates of the persons in their 30s 
and 40s tended to decline from 69.9% in 2005 to 48.4% in 2009 
and from 97.9% in 2005 to 89.0% in 2009, respectively. 
Changes of anti-HAV positive rates by area and
age from 2005 to 2009 
The antibody positive rates of the total subjects by year from 
2005 to 2009 are shown in detail in Table 3. The rates of young 
children aged less than 10 years was only 16.7% in Seoul in 
2005, but it skyrocketed to 73.3% in 2009. The rates of Incheon/ 
Gyeonggi/Gangwon and Honam/Jeju also increased rapidly 
from 30.0% in 2005 to 69.9% in 2009 and from 37.8% in 2005 to 
76% in 2009, respectively. Those of Chungcheong and Gyeongsang 
became higher from 44-43% in 2005 to 60-69% in 2009, 
respectively. The age with the lowest antibody positive rate in all 
areas in 2009 was 20s years by recording 10.4-13.3% and 10s 
years followed them by recording 17.8-30.1%. Interestingly, the 
rates of the persons in their 40s were reduced to 80% in Seoul and 
to 88.9-96.8% in other areas in 2009 compared to those in 2005. 
The positive rate of the persons in their 30s was 39-69.2%. All 
difference by area, year and age was statistically significant 
(P<0.001). The age-adjusted antibody positive rates by area are 
presented in Table 4. The rate in Seoul recorded the lowest level 
(59.7%) while the rate in Honam/Jeju showed the highest level 
(69.4%), and the difference by area was also statistically sig-
nificant (P<0.001).
DISCUSSION
This study investigated area- and age-adjusted anti-HAV 
positive rate from 2005 to 2009 by analyzing the results of totally Donghun Lee, et al. A nationwide seroprevalence of hepatitis A virus from 2005 to 2009  47
Table 3. Age-specific anti-HAV seroprevalence rate (%) by area and year
*
Area
Year
 Age 2005 2006 2007 2008 2009
Seoul  (n=6,791) 0-9 16.7 58.3 51.1 38.9  673.3
10-19 21.4 21.1 20.9 25.9 25.4
20-29 17.6 27.4 16.7 14.2 12.9
30-39 69.1 59.7 55.1 48.7 39.0
40-49 97.4 94.3 93.2 91.5 80.0
50+ 99.0 99.4 99.2 98.7 96.5
Total 71.6 65.1 63.7 60.4 47.7
Incheon, Gyeonggi and
  Gangwon (n=10,263)
0-9 30.0 52.6 40.9 47.4 69.9
10-19 22.9 16.1 13.2 18.3 17.8
20-29 18.9 30.2 14.5 15.3 10.4
30-39 64.2 71.0 61.2 58.8 49.3
40-49 99.0 94.9 95.0 92.8 91.5
50+ 99.0 99.0 99.3 99.5 99.5
Total 52.0 61.0 57.8 65.1 64.6
Chungcheong  (n=2,248) 0-9 44.4 50.0 25.0 61.5 59.7
10-19   9.1 35.3 21.1 50.0 21.4
20-29 11.1 43.8 28.6   9.7 12.2
30-39 40.0 62.5 71.1 72.4 47.8
40-49 99.0 99.0 99.0 83.6 88.9
50+ 99.0 96.0 97.8 99.0 98.9
Total 43.5 68.6 69.4 62.2 56.6
Gyeongsang  (n=3,871) 0-9 43.3 46.9 44.8 54.9 68.8
10-19 2.3  12.3 23.1 20.8 26.2
20-29 25.8 23.9 15.0 25.8 13.3
30-39 84.4 63.5 61.9 56.4 47.1
40-49 96.2 99.0 94.9 92.0 89.7
50+ 98.1 99.0 98.4 98.5 99.7
Total 53.2 57.5 63.5 65.6 56.4
Honam  and  Jeju  (n=1,967) 0-9 37.8 59.1 45.0 59.4 76.0
10-19 20.0 23.5 29.4 33.3 30.1
20-29 50.0 28.6 40.0 16.8 10.5
30-39 81.8 88.2 88.9 71.7 69.2
40-49 99.0 99.0 91.7 92.4 96.8
50+ 99.0 94.4 92.9 99.0 98.8
Total 59.4 68.5 63.7 61.8 74.0
* P-values by Chi-square test for area, year and age were all < 0.001.
HAV, hepatitis A virus.
25,140 cases of anti-HAV test from one central laboratory 
requested by 1,699 medical institutions around the nation. 
Although the nationwide anti-HAV positive rates were not large-
ly different from 62.5% in 2005 to 60.7% in 2009, the rates by 
area and age changed dynamically. The antibody positive rate of 
the young children aged less than 10 years increased sharply in 
the capital area for the recent five years, and the age which was 
the most vulnerable to hepatitis A infection was found to be 20s 
years with the seroprevalence rate of 11.9% which was followed 
by 10s years having the rate of 23.4%. The seropositive rates of 48  The Korean Journal of Hepatology Vol. 17. No. 1, March 2011
Table 4. Age-adjusted anti-HAV seroprevalence rate (%) by year and area
Area
Year
2005 2006 2007 2008 2009 Average
*
Seoul 60.3 64.0 60.2 57.5 56.5 59.7 
Incheon, Gyeonggi and    
Gangwon
60.5 64.8 58.6 59.5 59.5 60.6 
Chungcheong 56.5 68.9 63.5 67.0 59.9 63.2 
Gyeongsang 65.0 63.7 62.4 63.5 62.2 63.4 
Honam  and  Jeju 70.7 70.4 69.7 67.7 68.5 69.4 
* P-value by Chi-square test was<0.001.
HAV, hepatitis A virus.
the persons in their 30s and 40s were 48% and 89%, respectively, 
and particularly the rate of the persons in their 40s in Seoul was 
reduced to 80%. 
In South Korea, anti-HAV positive rate had been over 50% in 
the persons in their 10s and it had reached nearly 100% in adults 
in the 1970s and the early 1980s, but it reduced remarkably from 
the 1990s by recording 54% in the personsaged 21-25 years in 
the late 1990s and 20-23% and 40-42% in the personsaged 10-24 
years and 25-30 years, respectively in Seoul and Gyeonggi in the 
mid 2000s. The overall decrease of the antibody positive rate was 
found to move to older age.
4-7 This tendency was observed in 
other countries such Spain, Greece and Israel.
8-10 This epidemio-
logical change could show a regional difference between urban 
and rural areas and the difference by income level was also 
reported. It was also found in developing countries including the 
Middle East, China and Central and South America and a study 
conducted in Bangladesh revealed that income level provoked 
the epidemiological difference.
11-14 In South Korea, Song et al. 
reported that the anti-HAV positive rates of the persons in their 
20s and 30s (25.6%) were significantly lower in Seoul than in 
other areas (55.6%) in 2007, but Kim et al. did not find any 
significance difference in the rate between Seoul and Gyeonggi 
in 2007.
5,7 The study of Song et al. revealed that the positive rate 
of particularly Gangnam in Seoul was lower (20.0%) in the 
persons aged less than 40 years compared to the rate of other 
areas (55.6%). However, the number of the subjects in their study 
was not sufficient to compare the difference in the antibody 
positive rates by nationwide area and there has been no study on 
age- and area-adjusted rates based on Census in South Korea.
5
The subjects of this study were 25,140 patients out of 45,296 
for whom anti-HAV test were done by 1,699 medical institutions 
around the nation by excluding 20,156 ones for whom total 
anti-HAV test was requested along with IgM anti-HAV test 
because some of them could be acute hepatitis A patients. 
However, on what purposes the 25,140 subjects underwent total 
anti-HAV could not be defined, which was a limitation of this 
study. Medical institutions having asked SCL to conduct the 
antibody tests consist of hospitals or higher institutions in 
55%, clinics in 30% and public health centers and others in 15%. 
As the cases of hepatitis A went up dramatically in 2008 and 
2009, the public interest in the disease also increased to raise 
cases requesting the test by year. 
This study calculated nationwide area- and age-adjusted 
hepatitis A antibody positive rates with 2005 Census, the latest 
population survey as a standard. However, the number of cases of 
the test by area and year was not sufficient to obtain standardized 
positive rates by administrative districts, so the whole nation was 
arbitrarily divided into five areas- Seoul, Incheon/Gyeonggi/ 
Gangwon, Chungcheong, Gyeongsang and Honam/Jeju. As the 
antibody positive rate by gender was not significantly different in 
each age group and in each area, adjustment by gender was not 
applied. In addition, because this study examined the antibody 
positive rate of patients visiting hospitals rather than general 
population, their positive rate was likely to be lower than that of 
the general population and that can be a limitation of this study.
According to the result of this study, the antibody positive rate 
of the young children aged less than 10 years around the nation 
doubled from 33% in 2005 to 70% in 2009 and especially the 
increase was the largest in the capital area including Seoul. 
Vaccination against hepatitis A focusing on children had been 
conducted from 1997 and then the vaccination mainly for infants 
have been done. When the imported dose of hepatitis A vaccine 
for the last five years was examined, the vaccines for young 
children increased from 290,000 doses in 2005 to 400,000 doses 
in 2007, and 880,000 doses in 2009, while vaccine dose for 
adults were raised from 10,000 doses in 2006 to 20,000 in 2008 Donghun Lee, et al. A nationwide seroprevalence of hepatitis A virus from 2005 to 2009  49
and 620,000 doses in 2009. Even though some vaccines for chil-
dren were administered to adults due to the insufficient supply 
of vaccines for adults following the rapid increase of incidences 
hepatitis A in adults for the last three years, the numbers of 
vaccines for children are considered to show a continuous 
increase. Because children conventionally play an important role 
in the transmission of  HAV and the vaccination for children 
reduced the adult cases of hepatitis A outstandingly in the U.S., 
Israel and Chile, it is considered that universal vaccination 
against hepatitis A for children should be recommended in South 
Korea.
The persons in their 10s and 20s were found to be the most 
vulnerable to the infection of HAV with the lowest antibody 
positive rates from 2005 to 2009. In 2009, the positive rate of the 
persons in their 20s recorded the lowest level (12%) and it was 
followed by that of the persons in their 10s (23%), which was not 
significantly different by area. In the meantime, although the 
total antibody positive rate of the persons in their 30s was 48%, 
the rates by area were different significantly (39%, 69% and 48% 
in Seoul, Honam/Jeju and other areas, respectively). 
In particular, the positive rate of the persons in their 40s was 
lower in Seoul than in other areas. Therefore, even in persons in 
their early 40s living in the capital area becomes at risk of HAV 
infection although they have been thought to be relatively safe 
from the risk. The mortality rate of hepatitis A becomes higher at 
older age and the mortality rates of the persons in their 30s, 
40s, 50s and 60s are estimated to be 0.04-0.06%, 0.03-0.1%, 
0.08-0.23% and 0.58%, respectively.
15 Moreover, Kim et al. 
reported that factors affecting the severity with 716 patients with 
hepatitis A were hepatitis B virus carriers, history of alcohol 
drinking and old age.
16
In the U.S., around 200,000 cases of hepatitis A occurred to 
the mid 1990s and the cyclic epidemic with a cycle of 10-15 
years, but an active vaccination for children from 1996 
reduced its incidences considerably.
17 However, in South Korea 
the vaccination rate against hepatitis A for children reaches 
50-70%, which suggests the possibility of food-born transmission 
rather than children as a major source of infection. So, catch-up 
vaccination for the persons aged 10-29 years with a low antibody 
positive rate needs to be considered. The outstanding increase of 
vaccines for adults as well as those for children during recent 
years seems to be closely related with the decreased incidences 
of hepatitis A since 2010. Saab et al. insisted that if hepatitis 
A antibody positive rate was over 35% and anti-HAV test cost 
less than 25 U.S. dollars, vaccination without testing the anti-
body was cost-effective than vaccination after testing.
18 
Therefore, it is reasonable that persons aged less than 30 years 
undergo HAV vaccination without the antibody test while those 
aged over 30 years do after the test, but there have not been 
sufficient studies on the cost-effectiveness. Moreover, as this 
study found that the antibody positive rates were different by 
area and the seroprevalence rates of the persons in their 30s 
varied by area from 39% to 69%, the vaccination and the test 
should be conducted by considering the regional difference.
In conclusion, the hepatitis A antibody positive rate has 
changed rapidly in Korea for the last five years, and to prevent 
the nationwide spread of the hepatitis A, universal vaccination 
for children should be adapted and continuous monitoring and 
epidemiological studies are necessary. 
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